Glycine (as a marketed «nootropic»)

Glycine is an amino acid sold as a nootropic and promoted for chronic fatigue, with the promise of restoring energy and focus. There is no solid evidence that it helps with chronic fatigue, so no proven benefit for this use. Lasting tiredness usually has a treatable cause worth finding: sleep quality and schedule, deficiencies (iron, vitamin B12, thyroid), chronic conditions, mood, so it is worth discussing symptoms with a doctor and running basic tests. Glycine is harmless in this role, but do not take it instead of proper workup and treatment that does work, or you may miss the real cause.

ICD-10: R53 · ICD-11: MG22

Glycine is an amino acid sold as a "nootropic" and offered to children with delayed psychomotor and speech development. Studies have not shown convincing benefit for this use, and there is no evidence base behind it. What actually helps with developmental delay is early intervention: work with a speech therapist and a special-education specialist, plus follow-up with a clinician who looks for the cause of the delay. The substance itself is harmless in this role, but it should not replace treatment with proven benefit, or the child loses time on care that genuinely works.

ICD-10: F80-F89 · ICD-11: 6A0Z

Glycine is an amino acid sold as a "nootropic" and marketed to improve sleep. There is no solid evidence that it helps with insomnia or sleep problems: this use has no supporting data. What actually works for sleep is good sleep hygiene and cognitive behavioral therapy, plus medication chosen by a doctor when needed. The substance itself is harmless in this role, but do not take it instead of treatment with proven benefit, since that can mean missing care that works.

ICD-10: G47.0 · ICD-11: 7A00

Glycine is an amino acid sold in tablets as a "nootropic" and promoted for ischemic stroke to protect the brain. Studies have not shown a convincing benefit in stroke – there is no evidence base for this use. What actually helps is restoring blood flow within the first hours (thrombolysis, thrombectomy in a stroke unit), antiplatelet prevention, and rehabilitation. Glycine in this role is harmless, but do not use it instead of treatments with proven benefit – that risks losing time and the care that truly works.

ICD-10: I63 · ICD-11: 8B11

Glycine is an amino acid marketed as a nootropic for better memory and concentration. The effect at this use has not been shown: there is no solid evidence that it improves memory or attention in healthy people. When forgetfulness and trouble focusing bother you, sleep, physical activity, and treating the underlying cause help more – for example iron deficiency, thyroid problems, or anxiety. Glycine is safe in this role, but do not take it instead of an approach with proven benefit, so you don't miss the treatment you actually need.

Glycine is an amino acid sold as a mild nootropic and calming aid, including for stress and anxiety. Studies have not shown a convincing benefit for this use: there is no solid evidence base behind taking glycine for anxiety or stress. For marked or persistent anxiety, the approaches with real support are psychotherapy (cognitive behavioral therapy first) and, when a doctor decides, medications with proven efficacy. The substance itself is harmless in this role, but do not take it in place of therapy with proven benefit, since that can mean missing treatment that actually helps.

ICD-10: F41.9 · ICD-11: 6B0Z